Intramyocardial immunomodulation with human CD16+ monocytes to treat myocardial infarction in pig: a blind randomized preclinical trial.
Saved in:
| Title: | Intramyocardial immunomodulation with human CD16+ monocytes to treat myocardial infarction in pig: a blind randomized preclinical trial. |
|---|---|
| Authors: | Ascione R; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Bruno VD; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Johnson T; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Sammut E; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Bond A; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Lopez-Baz D; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Deutsch J; Faculty of Health Science, Langford Vets and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Bailey M; Faculty of Health Science, Langford Vets and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom., Chiribiri A; School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom., Patel A; Vascular Surgery, King's College London, London, United Kingdom., Baker A; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom., Modarai B; Vascular Surgery, King's College London, London, United Kingdom. |
| Source: | Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2024 Aug 07; Vol. 11, pp. 1427023. Date of Electronic Publication: 2024 Aug 07 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39171324 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intramyocardial immunomodulation with human CD16<superscript>+</superscript> monocytes to treat myocardial infarction in pig: a blind randomized preclinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ascione+R%22">Ascione R</searchLink>; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bruno+VD%22">Bruno VD</searchLink>; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Johnson+T%22">Johnson T</searchLink>; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sammut+E%22">Sammut E</searchLink>; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bond+A%22">Bond A</searchLink>; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lopez-Baz+D%22">Lopez-Baz D</searchLink>; Faculty of Health Science, Bristol Heart Institute and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Deutsch+J%22">Deutsch J</searchLink>; Faculty of Health Science, Langford Vets and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bailey+M%22">Bailey M</searchLink>; Faculty of Health Science, Langford Vets and Translational Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chiribiri+A%22">Chiribiri A</searchLink>; School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patel+A%22">Patel A</searchLink>; Vascular Surgery, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Baker+A%22">Baker A</searchLink>; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Modarai+B%22">Modarai B</searchLink>; Vascular Surgery, King's College London, London, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101653388%22">Frontiers in cardiovascular medicine</searchLink> [Front Cardiovasc Med] 2024 Aug 07; Vol. 11, pp. 1427023. <i>Date of Electronic Publication: </i>2024 Aug 07 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101653388 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2297-055X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222297055X%22">2297055X </searchLink><i>NLM ISO Abbreviation: </i>Front Cardiovasc Med <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39171324 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fcvm.2024.1427023 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1427023 Titles: – TitleFull: Intramyocardial immunomodulation with human CD16+ monocytes to treat myocardial infarction in pig: a blind randomized preclinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ascione R – PersonEntity: Name: NameFull: Bruno VD – PersonEntity: Name: NameFull: Johnson T – PersonEntity: Name: NameFull: Sammut E – PersonEntity: Name: NameFull: Bond A – PersonEntity: Name: NameFull: Lopez-Baz D – PersonEntity: Name: NameFull: Deutsch J – PersonEntity: Name: NameFull: Bailey M – PersonEntity: Name: NameFull: Chiribiri A – PersonEntity: Name: NameFull: Patel A – PersonEntity: Name: NameFull: Baker A – PersonEntity: Name: NameFull: Modarai B IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 08 Text: 2024 Aug 07 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2297-055X Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in cardiovascular medicine Type: main |
| ResultId | 1 |